Job Overview
Job description
- Salary:
- USD 90 - 150 per hour
- Location:
- United States
- Work arrangement:
- Remote
Role Summary
Mercor connects elite creative and technical talent with leading AI research labs. Headquartered in San Francisco, our investors include Benchmark , General Catalyst , Peter Thiel , Adam D'Angelo , Larry Summers , and Jack Dorsey .
- Position: Medical Writer
- Type: Contract
- Compensation: $90–$150/hour
- Location: Remote
- Commitment: 20–25 hours/week
- Role Responsibilities
Generate and validate high-quality, synthetic clinical trial data.
Author full CSR sections and design prompts, golden outputs, and rubrics.
Quantify the ability of an AI agent in CSR task authorship.
Work independently and asynchronously to meet deadlines.
Collaborate with AI research teams to improve training data quality.
Requirements
- 5+ years of experience.
- PhD or equivalent.
- Experience with pre-market (Phases 1-3) clinical trial data and report authorship.
- Comfortable with full-document, long-horizon authorship.
- Location: US or Canada.
- Preferred
- 10–25 years of experience.
- 30+ hours/week availability.
- Application Process (Takes 20–30 mins to complete)
- Upload resume
- AI interview based on your resume
- Submit form
- Resources & Support
- For details about the interview process and platform information, please check:
Additional Information
PS: Our team reviews applications daily. Please complete your AI interview and application steps to be considered for this opportunity.
- Role:
- Medical Writer - Fully Remote | Upto $150/hr
- Job Type:
- Contractor
Company profile
mercor
mercor.comMercor is an AI data company that connects domain experts across hundreds of professional fields with frontier AI labs and enterprises. Experts on its platform train and evaluate AI models, and its APEX benchmark family measures how AI performs on real-world professional work. Mercor Enterprise helps large companies capture how their most skilled people work and turn that expertise into AI agents. Founded in 2023, the company has offices in San Francisco, NYC and London.
- Founded
- 2023
- Funding Stage
- Series C